ArticleImmunotherapy advances2026

Overall survival by baseline and on-treatment systemic immune-inflammation index in patients with advanced cancer receiving immune checkpoint inhibitors: a large single-centre cohort study.

Oliver John Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.